B. Riley Wealth Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-881
Closed -$217K 1621
2022
Q3
$217K Buy
881
+30
+4% +$8.1K 0.01% 1188
2022
Q2
$211K Buy
851
+54
+7% +$14.6K 0.01% 1027
2022
Q1
$264K Sell
797
-2,099
-72% -$646K 0.01% 1075
2021
Q4
$1.04M Buy
2,896
+441
+18% +$149K 0.03% 519
2021
Q3
$800K Buy
2,455
+1,108
+82% +$375K 0.03% 595
2021
Q2
$421K Buy
1,347
+281
+26% +$86.2K 0.01% 855
2021
Q1
$340K Sell
1,066
-968
-48% -$310K 0.01% 934
2020
Q4
$660K Buy
2,034
+393
+24% +$109K 0.04% 446
2020
Q3
$455K Buy
+1,641
New +$473K 0.02% 566
2019
Q4
Sell
-1,993
Closed -$355K 919
2019
Q3
$355K Buy
1,993
+42
+2% +$9.08K 0.04% 531
2019
Q2
$510K Buy
1,951
+148
+8% +$39.3K 0.06% 367
2019
Q1
$517K Buy
1,803
+200
+12% +$66.5K 0.06% 331
2018
Q4
$523K Sell
1,603
-263
-14% -$91.4K 0.07% 284
2018
Q3
$840K Buy
1,866
+42
+2% +$16.6K 0.1% 217
2018
Q2
$747K Sell
1,824
-5
-0.3% -$1.81K 0.1% 223
2018
Q1
$533K Buy
+1,829
New +$464K 0.07% 294
2017
Q1
Sell
-1,999
Closed -$226K 570
2016
Q4
$226K Sell
1,999
-207
-9% -$24K 0.05% 420
2016
Q3
$285K Sell
2,206
-30
-1% -$3.59K 0.06% 415
2016
Q2
$245K Buy
2,236
+59
+3% +$5.87K 0.05% 469
2016
Q1
$206K Buy
+2,177
New +$184K 0.05% 470
2015
Q4
Sell
-2,243
Closed -$209K 627
2015
Q3
$209K Buy
+2,243
New +$198K 0.05% 469

Other funds holding ABMD

B. Riley Wealth Advisors's ABMD Position: Q4 2022 in Review

B. Riley Wealth Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 881 shares — an estimated $217K sold.

B. Riley Wealth Advisors first reported a position in ABMD in Q3 2015 and held it in 21 quarters. The position peaked at $1.04M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • B. Riley Wealth Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 881 Abiomed Inc shares in Q4 2022, an estimated $217K.
  • B. Riley Wealth Advisors first reported a position in Abiomed Inc in Q3 2015 and held it in 21 quarters.
  • B. Riley Wealth Advisors's Abiomed Inc position peaked at $1.04M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2022, filed 21 Feb 2023.